Vulvovaginal Candidiasis Market Global Growth By 2030 | Industry Analysis by Competitor Strategy, High Emerging, Sales Revenue, Competitive Landscape

Web 3.0 market

The global Vulvovaginal Candidiasis (VVC) market size reached USD 971.51 Million in 2022 and is expected to register a revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Global rise in vulvovaginal candidiasis infection in women, rising regulatory approvals for the treatment of vulvovaginal candidiasis, and increasing number of clinical research studies related to the treatment of vulvovaginal candidiasis are some of the key factors driving the market growth of the vulvovaginal candidiasis market.

Vulvovaginal candidiasis is one of the primary triggers of vulvovaginal irritation and discharge. The condition is characterized by Candida species-induced inflammation. About one-third of cases are caused by candidal vulvovaginitis. Statistics from the National Center of Biotechnology Information (NCBI) show that it accounts for a third of all vulvovaginitis cases in reproductive-aged women and that 70% of women report having had candidal vulvovaginitis at some point in their lives. Recurrent candidal vulvovaginitis affects 8% of women. Several approaches, including treatment with oral or topical antifungals, minimize symptomatic clinical recurrences in women with Recurrent Vulvovaginal Candidiasis (RVVC).

The researcher also discusses the recent trends and developments including joint ventures, collaborations, investments, product launches and acquisitions and mergers constitute a substantial part of the research on the Vulvovaginal Candidiasis market for the forecast period from 2022 to 2030. The report will empower companies to understand the opportunities, adapt to their consumer demands, needs, and concentrate on their best end-users.

You Can Download Free Sample PDF Copy of Vulvovaginal Candidiasis Market at @

Some Key Highlights in the Report

  • The retail pharmacies segment accounted for the largest revenue share in 2022. Retail pharmacists help to prepare and administer medicines, counsel clients on prescription administration and alert them to potential drug interactions. Customers can also speak with retail pharmacists about over-the-counter medications and other basic healthcare needs. Retail pharmacists can fill prescriptions on-site, which can be more convenient for patients who want a more efficient discharge process rather than filling prescriptions at an off-site location. This streamlines a patient’s healthcare pathway and improves their overall experience. Retail pharmacies enable the comprehensive shift of the patient health care journey, improve patient satisfaction, and enable greater qualitative outcomes. These are the major factors driving revenue growth of the segment.
  • The fluconazole segment is expected to grow at a steady revenue CAGR during the forecast period. One of the most often used antifungal medications is fluconazole, a member of the triazole family. It is a medication that the FDA has approved for the treatment of systemic Candida infections, such as candidemia and disseminated candidiasis, as well as vaginal, oropharyngeal, and esophageal candidiasis, and urinary tract infections. The overall therapeutic success of weekly fluconazole is greatly influenced by both its pharmacokinetic properties and its safety. Weekly fluconazole administration for six months reduced the occurrence of recurrent vulvovaginal candidiasis by more than 90% in randomized, prospective, placebo-controlled clinical trials. Fluconazole, a drug that is commonly used to treat yeast infections, has been approved by the FDA and is rising demand for this market.

The reports cover key developments in the Vulvovaginal Candidiasis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships and collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Vulvovaginal Candidiasis market are anticipated to lucrative growth opportunities in the future with the rising demand for Vulvovaginal Candidiasis in the global market. The market is expected to grow at a significant CAGR during the forecast period.

The major players covered in this report

Mycovia Pharmaceuticals, Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Pfizer, , Cadila Pharmaceuticals., SCYNEXIS, Inc., Grupo Ferrer International S.A., Phathom Pharmaceuticals, Inc., and Lupin.

Any Query or Discount? Ask our [email protected]

Emergen Research has segmented the global vulvovaginal candidiasis market on the basis of drug type, route of administration, distribution channel, and region:

  • Drug Type Outlook (Revenue, USD Million; 2019-2030)
    • Clotrimazole
    • Fluconazole
    • Ketoconazole
    • Terbinafine
    • Terconazole
    • Others
  • Route of Administration Outlook (Revenue, USD Million; 2019-2030)
    • Oral
    • Topical
    • Intravenous
  • Distribution Channel Outlook (Revenue, USD Million; 2019-2030)
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Vulvovaginal Candidiasis Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America Brazil, Argentina, Colombia and Chile etc.)

Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Browse the comprehensive TOC and data tables @

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Vulvovaginal Candidiasis market evolving?
  • What is driving and restraining the Vulvovaginal Candidiasis market?
  • How will each Vulvovaginal Candidiasis submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
  • How will the market shares for each Vulvovaginal Candidiasis submarket develop from 2022 to 2030?
  • What will be the main driver for the overall market from 2022 to 2030?
  • Will leading Vulvovaginal Candidiasis markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Vulvovaginal Candidiasis projects for these leading companies?
  • How will the industry evolve during the period between 2022 and 2030? What are the implications of Vulvovaginal Candidiasis projects taking place now and over the next 10 years?

Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.

Top Trending Reports:

healthcare crm market

horticulture lighting market

Gas Sensors Market

silicon photonics devices market

advanced driver assistance system market

Neurosurgery Market

Data Center Rack Market

wood preservatives market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Compression Therapy Market | Smart Insulin Pens Market

Latest Report:  Medical Electrodes Market |  Olfactory Neuroblastoma Market

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *